Esperion Therapeutics, Inc.

NEW YORK STATE COMMON RETIREMENT FUND ESPR

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/12/2026

Shares

63,900

Value ($000)

236

Weight

0.0%

2019 Q4 - 2025 Q4 (22 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/12/2026	236	0.0%	63,900	12/31/2025
2025 Q3	11/3/2025	83	0.0%	31,400	9/30/2025
2025 Q2	10/8/2025	31	0.0%	31,400	6/30/2025
2025 Q1	10/8/2025	45	0.0%	31,400	3/31/2025
2024 Q4	10/8/2025	69	0.0%	31,400	12/31/2024
2024 Q3	10/8/2025	52	0.0%	31,400	9/30/2024
2024 Q2	10/8/2025	170	0.0%	76,500	6/30/2024
2023 Q2	10/8/2025	1	0.0%	628	6/30/2023
2023 Q1	10/8/2025	40	0.0%	25,028	3/31/2023
2022 Q4	10/8/2025	283	0.0%	45,381	12/31/2022
2022 Q3	11/8/2022	304	0.0%	45,379	9/30/2022
2022 Q2	8/4/2022	195	0.0%	30,590	6/30/2022
2022 Q1	7/1/2022	123	0.0%	26,429	3/31/2022
2021 Q4	2/2/2022	110	0.0%	21,929	12/31/2021
2021 Q3	11/2/2021	597	0.0%	49,575	9/30/2021
2021 Q2	8/2/2021	1,048	0.0%	49,543	6/30/2021
2021 Q1	5/11/2021	1,691	0.0%	60,271	3/31/2021
2020 Q4	2/8/2021	1,567	0.0%	60,271	12/31/2020
2020 Q3	11/5/2020	2,530	0.0%	68,068	9/30/2020
2020 Q2	8/7/2020	2,851	0.0%	55,568	6/30/2020
2020 Q1	5/6/2020	1,558	0.0%	49,418	3/31/2020
2019 Q4	2/5/2020	3,285	0.0%	55,097	12/31/2019